BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26302995)

  • 1. The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE.
    Halmer R; Davies L; Liu Y; Fassbender K; Walter S
    Cell Physiol Biochem; 2015; 37(1):269-75. PubMed ID: 26302995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LPS receptor, CD14, in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Walter S; Doering A; Letiembre M; Liu Y; Hao W; Diem R; Bernreuther C; Glatzel M; Engelhardt B; Fassbender K
    Cell Physiol Biochem; 2006; 17(3-4):167-72. PubMed ID: 16543733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
    Göbel K; Schuhmann MK; Pankratz S; Stegner D; Herrmann AM; Braun A; Breuer J; Bittner S; Ruck T; Wiendl H; Kleinschnitz C; Nieswandt B; Meuth SG
    Eur J Immunol; 2014 Aug; 44(8):2295-305. PubMed ID: 24811005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis.
    Berve K; Michel J; Tietz S; Blatti C; Ivan D; Enzmann G; Lyck R; Deutsch U; Locatelli G; Engelhardt B
    Eur J Immunol; 2024 Jun; 54(6):e2350761. PubMed ID: 38566526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFL7 reduces CNS inflammation in mouse.
    Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
    Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
    Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
    Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: a role in immune cells and vascular cells of the blood-brain barrier.
    Flynn KM; Michaud M; Madri JA
    Am J Pathol; 2013 Apr; 182(4):1322-36. PubMed ID: 23416161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
    Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
    Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS.
    Zekki H; Feinstein DL; Rivest S
    Brain Pathol; 2002 Jul; 12(3):308-19. PubMed ID: 12146799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.
    Vanheusden M; Broux B; Welten SPM; Peeters LM; Panagioti E; Van Wijmeersch B; Somers V; Stinissen P; Arens R; Hellings N
    Sci Rep; 2017 Apr; 7(1):663. PubMed ID: 28386103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
    Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
    Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.